Sodium Bicarbonate Injection USP, 8.4%, 50 mEq/50 mL Vial by Exela Pharma Sciences: Recall Expansion - Due to Vial Breakage

Exela Pharma Sciences, LLC, (Exela) is expanding their recall, adding fourteen (14) lots to the ongoing voluntary recall of forty-nine (49) lots of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL vial, 20-count carton. A total of 63 lots are now being recalled to the consumer level. The additional lots were distributed October 26, 2021 through April 25, 2022.

Click here for additional information.